Resource Hub
VIRTUAL TOUR
CONTACT US
Our Company
About Us
Our Journey
Leadership
Scientific and BD Team
Aragen Advantage
Global Locations
Media & Events
Recognitions
Investors
Annual Reports and Annual Returns
Corporate Governance
Services
Small Molecules
Discovery
Intox Safety Assesment
Aragen Integrated Drug Discovery (AIDD)
Integrated Drug Discovery
Chemistry
Biology
Safety Assessment
Highly Potent API (HPAPI)
Development & Manufacturing
Drug Substance - new
Drug Substance
Drug Product
Analytical Development
Performance Chemicals
Custom Chemical Synthesis
Commercial Manufacturing
Large Molecules (Biologics)
Discovery
Integrated Discovery
Molecular Biology
Antibody Discovery
Protein Sciences
Cell Line Development 2
Cell Line Development
Biology
Development & Manufacturing
Process Research & Development
Bioproduction
Developability & Analytics
GMP Manufacturing
Custom Solutions
Integrated Peptide Drug Discovery Platform
integrated Drug Substance + Drug Product Solution
Our Responsibility
Digital & AI (DnA)
EHS & Sustainability
Strategic Supply Chain Management
Quality
IP Protection & Data Security
Employee Welfare
Corporate Social Responsibility
Corporate Governance
Careers
Working at Aragen
Career Opportunities
Meet Our People
Caution Notice
Close Search
Search
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
GET IN TOUCH
Back to Resources
Posters
Filter by Science
All
All
Analytical
Biologics
Biology
Chemistry
Development
Ecotoxicology
Formulations BU
Intox
Manufacturing
NBEs Intox
PCET
SAS/Toxicology
Therapeutic Impact of an ALK5 Inhibitor Across Multiple Preclinical Fibrosis Models
Enhancing mAb platform process using Membrane chromatography (Affinity/Protein-A, using Sartobind Rapid A) for FIH molecules with focus on Optimizing cost and Accelerating timelines
Decoding the Conformational Plasticity of Ternary Complexes for Protacs’ Differential Activity
In vitro
phototoxicity validation study
Reliable and Reproducible Preclinical Rodent Models of MAS
Phenotypic Characterization of Bleomycin-Induced Pulmonary Fibrosis Model
Column Head Loading in SFC
Blood Brain Permeability and CNS Bioavailability
In vitro/In vivo Correlation of Permeability
Learn more about our end-to-end capabilities
×
Contact An Expert Today!
Contact Us
+
+
Back to Resources
